Normal electrical properties of hippocampal neurons modelling early Huntington disease pathogenesis

Brain Research

Volumn 1139, Issue 1, 2007, Pages 226-234

  Shelbourne, Peggy ^a   Coote, Edward ^a   Dadak, Selma ^a   Cobb, Stuart R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Hippocampus; Huntington disease; Repeat instability; Triplet repeat

Indexed keywords

ADENINE; CYTOSINE; GUANINE; POLYGLUTAMINE; TRINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; GENE; GENE EXPRESSION PROFILING; HD GENE; HIPPOCAMPUS; HUNTINGTON CHOREA; MEMBRANE ELECTROPHYSIOLOGY; MOOD DISORDER; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SYMPTOM; SYNAPTIC TRANSMISSION; TRINUCLEOTIDE REPEAT; WHOLE CELL;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HUNTINGTON DISEASE; MATCHED-PAIR ANALYSIS; MEMBRANE POTENTIALS; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; TRINUCLEOTIDE REPEAT EXPANSION;

MUS;

EID: 33847291740     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.12.091     Document Type: Article

References (44)

1. Aghajanian G.K., and Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse 3 (1989) 331-338
2. Beniczky S., Keri S., Antal A., Jakab K., Nagy H., Benedek G., Janka Z., and Vecsei L. Somatosensory evoked potentials correlate with genetics in Huntington's disease. NeuroReport 13 (2002) 2295-2298
3. Buhl E.H., Cobb S.R., Halasy K., and Somogyi P. Properties of unitary IPSPs evoked by anatomically identified basket cells in the rat hippocampus. Eur. J. Neurosci. 7 (1995) 1989-2004
4. Cudkowicz M., and Kowall N.W. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann. Neurol. 27 (1990) 200-204
5. de la Monte S.M., Vonsattel J.P., and Richardson Jr. E.P. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47 (1988) 516-525
6. de Tommaso M., De Carlo F., Difruscolo O., Massafra R., Sciruicchio V., and Bellotti R. Detection of subclinical brain electrical activity changes in Huntington's disease using artificial neural networks. Clin. Neurophysiol. 114 (2003) 1237-1245
7. Disterhoft J.F., Thompson L.T., Moyer Jr. J.R., and Mogul D.J. Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci. 59 (1996) 413-420
8. Disterhoft J.F., Wu W.W., and Ohno M. Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimer's disease. Ageing Res. Rev. 3 (2004) 383-406
9. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., and Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19 (1999) 1189-1202
10. Geiger J.R., and Jonas P. Dynamic control of presynaptic Ca(2+) inflow by fast-inactivating K(+) channels in hippocampal mossy fiber boutons. Neuron 28 (2000) 927-939
11. Graveland G.A., Williams R.S., and DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227 (1985) 770-773
12. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., and Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23 (1999) 181-192
13. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
14. Jason G.W., Suchowersky O., Pajurkova E.M., Graham L., Klimek M.L., Garber A.T., and Poirier-Heine D. Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch. Neurol. 54 (1997) 1081-1088
15. Jeste D.V., Barban L., and Parisi J. Reduced Purkinje cell density in Huntington's disease. Exp. Neurol. 85 (1984) 78-86
16. Johnston A.R., Black C., Fraser J., and MacLeod N. Scrapie infection alters the membrane and synaptic properties of mouse hippocampal CA1 pyramidal neurons. J. Physiol. 500 (1997) 1-15
17. Kennedy L., and Shelbourne P.F. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?. Hum. Mol. Genet. 9 (2000) 2539-2544
18. Kennedy L., Evans E., Chen C.-M., Craven L., Detloff P.J., Ennis M., and Shelbourne P.F. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet. 12 (2003) 3359-3367
19. Kennedy L., Shelbourne P.F., and Dewar D. Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis. Brain Res. 1039 (2005) 14-21
20. Klapstein G.J., Fisher R.S., Zanjani H., Cepeda C., Jokel E.S., Chesselet M.-F., and Levine M.S. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86 (2001) 2667-2677
21. Landfield P.W., and Pitler T.A. Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science 226 (1984) 1089-1092
22. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., Cepeda C., Calvert C.R., Jokel E.S., Klapstein G.J., Ariano M.A., Levine M.S., DiFiglia M., and Aronin N. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's Disease. J. Neurosci. 21 (2001) 9112-9123
23. Lange H., Thorner G., Hopf A., and Schroder K.F. Morphometric studies of the neuropathological changes in choreatic diseases. J. Neurol. Sci. 28 (1976) 401-425
24. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., and Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 119 (1996) 1633-1645
25. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., Robbins T.W., and Sahakian B.J. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121 (1998) 1329-1341
26. Levine M.S., Klapstein G.J., Koppel A., Gruen E., Cepeda C., Vargas M.E., Jokel E.S., Carpenter E.M., Zanjani H., Hurst R.S., Efstratiadis A., Zeitlin S., and Chesselet M.F. Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knock-in mouse models of Huntington's disease. J. Neurosci. Res. 58 (1999) 515-532
27. Li H., Li S.H., Johnston H., Shelbourne P.F., and Li X.J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25 (2000) 385-389
28. Li H., Li S.H., Yu Z.X., Shelbourne P., and Li X.J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21 (2001) 8473-8481
29. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., and Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19 (1999) 10428-10437
30. Macdonald V., and Halliday G. Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol. Dis. 10 (2002) 378-386
31. Mann D.M., Oliver R., and Snowden J.S. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. 85 (1993) 553-559
32. Morton A.J., Faull R.L.M., and Edwardson J.M. Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. Brain Res. Bull. 56 (2001) 111-117
33. Moyer Jr. J.R., Thompson L.T., Black J.P., and Disterhoft J.F. Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J. Neurophysiol. 68 (1992) 2100-2109
34. Murphy K.P., Carter R.J., Lione L.A., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., and Morton A.J. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 20 (2000) 5115-5123
35. Murphy G.G., Fedorov N.B., Giese K.P., Ohno M., Friedman E., Chen R., and Silva A.J. Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout mice. Curr. Biol. 14 (2004) 1907-1915
36. Power J.M., Wu W.W., Sametsky E., Oh M.M., and Disterhoft J.F. Age-related enhancement of the slow outward calcium-activated potassium current in hippocampal CA1 pyramidal neurons in vitro. J. Neurosci. 22 (2002) 7234-7243
37. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., Caplan K., Marek K., Seidman L.J., Makris N., Jenkins B.G., and Goldstein J.M. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60 (2003) 1615-1620
38. Shelbourne P.F., Killeen N., Hevner R.F., Johnston H.M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D.R., and Myers R.M. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8 (1999) 763-774
39. Spargo E., Everall I.P., and Lantos P.L. Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J. Neurol., Neurosurg. Psychiatry 56 (1993) 487-491
40. Strong T.V., Tagle D.A., Valdes J.M., Elmer L.W., Boehm K., Swaroop M., Kaatz K.W., Collins F.S., and Albin R.L. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet. 5 (1993) 259-265
41. Tellez-Nagel I., Johnson A.B., and Terry R.D. Studies on brain biopsies of patients with Huntington's chorea. J. Neuropathol. Exp. Neurol. 33 (1974) 308-332
42. Usdin M.T., Shelbourne P.F., Myers R.M., and Madison D.V. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8 (1999) 839-846
43. Verma-Ahuja S., Evans M.S., and Pencek T.L. Evidence for decreased calcium dependent potassium conductance in hippocampal CA3 neurons of genetically epilepsy-prone rats. Epilepsy Res. 22 (1995) 137-144
44. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577